Holen Sie sich die Stockscreener-App
2.43
11.64%
-0.32
Handel nachbörslich:
2.46
0.03
+1.23%
Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | -0.3052 | 0.1054 |
Operating Expenses
|
5.97%
4.7858
|
5.0895 | 4.3694 | 3.3311 | 4.459 |
| Operating Income/Loss |
5.97%
-4.7858
|
-5.0895 | -4.3694 | -3.3311 | -4.459 |
| Income/Loss From Continuing Operations Before Tax |
16.46%
-4.7351
|
-5.6679 | -4.4295 | -3.2635 | -4.4747 |
| Income Tax Expense/Benefit |
289.00%
0.5493
|
0.1412 | 0.1005 | 0.5047 | 0.011 |
| Income/Loss From Continuing Operations After Tax |
9.03%
-5.2844
|
-5.8091 | -4.5301 | -3.7682 | -4.4857 |
|
Net Income/Loss
|
9.03%
-5.2844
|
-5.8091 | -4.5301 | -3.7682 | -4.4857 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
15.35%
35.00
|
30.34 | 28.69 | 1.608 | 26.53 |
| Diluted Average Shares |
15.35%
35.00
|
30.34 | 28.69 | 1.608 | 26.53 |
| Basic Earnings Per Share |
21.05%
-0.15
|
-0.19 | -0.16 | -0.11 | -0.17 |
| Diluted Earnings Per Share |
21.05%
-0.15
|
-0.19 | -0.16 | -0.11 | -0.17 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):